Study Conduct

Survey: Global clinical operations need to unify clinical applications

Wednesday, June 21, 2017

There is an industry-wide drive toward a unified clinical operating model, according to the Veeva 2017 Unified Clinical Operations Survey, one of the industry’s largest annual surveys of clinical operations professionals. The new research from Veeva Systems reveals that nearly all respondents cite the need to unify their clinical applications, including EDC, CTMS and eTMF. More than 60% say faster study execution and improved study quality are the top drivers toward a unified clinical model, which is characterized by end-to-end processes and systems, visibility across the clinical life cycle and modern information systems.

[Read More]

Analysis: Services that ease site burden enhance clinical trial enrollment

Monday, June 19, 2017

BBK Worldwide, a clinical trial recruitment, engagement and technology company, has released results of a data analysis across a broad spectrum of trials. The findings confirm the premise that alleviating site staff of many of the mechanical aspects of clinical trial patient management allows more time for personal patient care, creating an enhanced clinical trial experience for patients and site staff alike. Results of the analysis show that patient-centric services have a positive impact on site staff satisfaction ratings and boost favorable opinions of clinical trial sponsors—the prelude to the coveted status of “sponsor of choice.”

[Read More]

Survey: Ridesharing is on the rise for clinical trials

Friday, June 16, 2017

The results of a survey of 432 clinical trial research sites reveals that only 44% of sites offer patient transportation assistance, underscoring a long-standing barrier that pharmaceutical companies face in recruiting and retaining patients for clinical trials.

[Read More]

goBalto, Informa partner on global site selection

Friday, June 16, 2017

goBalto, a provider of cloud-based clinical study startup (SSU) solutions, announced its partnership with Citeline, part of Informa’s Pharma Intelligence vertical, to integrate data from Citeline’s intelligence platforms—including Trialtrove and Sitetrove—with goBalto’s Select. Indexing information captured by Citeline on more than 390,000 investigators across over 265,000 trials in more than 170 countries to the award-winning Select application aids in providing a data driven approach to weighing selection and performance variables in the identification of sites and target populations ideally suited to studies.

[Read More]

Bridging Clinical Research and Clinical Health Care Collaborative to launch

Wednesday, June 14, 2017

In 2018, the Bridging Clinical Research and Clinical Health Care Collaborative will bring together industry leaders from pharma, biotech, CROs, healthcare organizations, advocacy groups and the FDA to advance the participation of patients and physicians in the conduct of clinical trials. The conference will be April 4–5, 2018, at the Gaylord National Resort and Conference Center in National Harbor, Maryland.

[Read More]

iSpecimen launches online marketplace for human biospecimens

Tuesday, June 13, 2017

iSpecimen launched the iSpecimen Marketplace—an online, data-rich platform that connects life science researchers who need human biospecimens to the healthcare organizations that have them. Using a powerful, multi-faceted search platform, the marketplace enables medical researchers to intuitively search millions of available human biospecimens and solves one of the research industry’s biggest challenges—how to compliantly obtain quality biospecimens in a cost-effective manner. Through the marketplace, researchers gain instant access to iSpecimen’s growing, federated network of healthcare providers and biobanks, giving network participants (specimen providers) the opportunity to more broadly contribute to medical research as well as their bottom line.

[Read More]

Novartis, IBM Watson Health partner on outcomes-based care in advanced breast cancer

Monday, June 12, 2017

Novartis announced a first-of-its-kind collaboration with IBM Watson Health on an initiative to optimize cancer care and improve patient outcomes. The two companies will collaborate to explore development of a cognitive solution that uses real-world data and advanced analytical techniques with the aim to provide better insights on the expected outcomes of breast cancer treatment options.

[Read More]

ProSciento, OWL Metabolomics partner on NAFLD/NASH trial recruitment

Monday, June 12, 2017

ProSciento, a full scope clinical R&D services provider focused exclusively on metabolic diseases, and OWL Metabolomics, a biotechnology company pioneering virtual biopsy assays for the diagnosis of NAFLD/NASH, announced an exclusive, multi-year collaboration aimed at identifying individuals who are eligible for enrollment into clinical trials of therapeutic candidates to treat NAFLD (non-alcoholic fatty liver disease) and NASH (steatohepatitis).

[Read More]